eTMF: Revolutionizing Clinical Trial Documentation in Digital Healthcare
When it comes to clinical trials for pharmaceuticals, it is widely recognized that they are an indispensable step in verifying the efficacy and safety of new drugs. However, the clinical trial process not only involves large sample sizes but also entails long durations and high costs; therefore, manual recording, paper-based submission, and written review are entirely incapable of improving work efficiency. With the increasing prevalence of electronic technologies, electronic clinical trials have become an inevitable trend.
In practice, electronic clinical trials involve distinct functional modules across different stages, such as Electronic Data Capture (EDC), Trial Data Management System (TDMS) for end-to-end clinical data management, and Clinical Trial Management System (CTMS). Today, we will focus on another specialized subset: the eTMF.
What is eTMF?
eTMF, full name: electronic Trial Master File, generally translated as “electronic trial master file management.” It refers to specialized content management for documents throughout the entire lifecycle of pharmaceutical clinical trials.
Typically, to comply with governmental regulatory requirements for clinical trials of pharmaceutical products, every organization involved in the oversight of clinical trials must retain essential trial-related documents. Therefore, to preserve this information, documents are stored either in physical file cabinets within the Trial Master File (TMF) or in an electronic TMF system.
As workloads increase, government agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are actively exploring new initiatives to reduce costs and accelerate the clinical trial approval process by engaging in the regulation of clinical trial procedures. In the United States, the FDA has established Title 21 Code of Federal Regulations Part 11 (21 CFR Part 11), which primarily governs electronic records and electronic signatures, to support their use in clinical trials. In Europe, the EMA has also issued policies supporting the use of electronic signatures in clinical trials.
By automating electronic enterprise content management, commercial risks are reduced while ensuring regulatory compliance. Thus, the transition from TMF to eTMF has gradually gained widespread adoption.
However, a key pain point is that eTMF must comply with various regulatory requirements; poor management or underperformance can lead to significant risks.
The primary responsibility of the eTMF is to manage various types of documents generated during clinical trials separately, including general documents, archival documents, and submission documents, while maintaining detailed records of all document-related activities.
eTMF processes include:
Most developed eTMF systems have the following functions:
Document creation, quality control, and approval;
Compliant electronic signature;
Document Version and Revision History;
Full-text document search mechanism;
Complete Report Summary System;
Export Entire Project;
Automatic synchronization of file modifications, advanced search;
Virtual document editing for large, complex deliverables;
Automatic Information Exchange;
Comprehensive Documentation Catalog;
Configurable raw data;
Document list and necessary document tracking;
Pre-configured, customizable workflows;
Formal folder structure and naming conventions;
Benefits of Implementing an eTMF:
Save time for sponsors and investigators, and improve the efficiency of clinical trials;
Improve the quality and completeness of clinical trial documentation;
Reduce clinical trial costs;
Establish seamless collaboration among sponsors, contract research organizations (CROs), and other third parties;
Track the progress of clinical trial documentation to ensure rapid and secure access to files during and after the trial;
Simplify and accelerate the planning of complex clinical trial documents;
Achieve higher efficiency in clinical trials;
Improve the accuracy of research findings;
Expand licensed knowledge sharing;
Reduce record storage costs;
Current Status of eTMF Development in China and Abroad
According to a 2014 survey by Veeva, a U.S.-based software company specializing in the life sciences sector, contract research organizations (CROs) have been relatively slow to adopt next-generation methods for documenting study records, with only 13% utilizing the most advanced technologies. In China’s drug clinical trial processes, paper-based systems generally remain prevalent; nearly 90% of clinical trials still rely on manual record-keeping, paper submissions, and written reviews. Although healthcare institutions have been slow to change, there is no shortage of foreign companies providing electronic document management services for clinical trials.
According to VCBeat, current international players include Veeva, GoBalto, NextDocs, SureClinical, ConsultParagon, DB Integrations, and EMC. Among them, two have entered the Chinese market: global software application services giant Veeva, which officially entered China in 2011 and was listed on the New York Stock Exchange in October 2013; and EMC, which has been present in China for nearly 20 years. Ironically, EMC gained prominence in China due to the “Secretary Gate” scandal.
In China, although there is a significant gap compared to Western developed countries in the management of electronic documents for new drug research, we have identified one company, Beijing BioKnow, whose developed product, BioKnow-eTMF, is specifically designed for clinical trial document management.
Note: CRO refers to an academic or commercial scientific organization. The sponsor may delegate certain tasks and responsibilities in clinical trials to such organizations, and such delegation must be documented in writing.
VCBeat’s Chief Advisor for Analysis of Trending English Terms in Internet Healthcare: Zhao Xinyuan, current CEO of Beijing Yingtai Kelong Technology Co., Ltd., and Member of the HL7 China Technical Steering Committee.
VCBeat is currently recruiting volunteers to analyze trending English terms in digital health. We welcome you to share your expertise. Please follow the VCBeat WeChat official account and contact us!